ID   RXF 631L
AC   CVCL_A780
SY   RXF-631L; RXF631L; RXF 631; RXF-631; RXF631
DR   ChEMBL-Cells; CHEMBL3307735
DR   ChEMBL-Targets; CHEMBL614888
DR   Cosmic; 1436044
DR   NCI-DTP; RXF 631
DR   PubChem_Cell_line; CVCL_A780
DR   Wikidata; Q54951509
RX   PubMed=2041050;
RX   PubMed=22336246;
WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Part of: JFCR39 cancer cell line panel.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 15
//
RX   PubMed=2041050; DOI=10.1093/jnci/83.11.757;
RA   Monks A., Scudiero D.A., Skehan P., Shoemaker R.H., Paull K.D.,
RA   Vistica D.T., Hose C.D., Langley J., Cronise P., Vaigro-Wolff A.,
RA   Gray-Goodrich M., Campbell H., Mayo J.G., Boyd M.R.;
RT   "Feasibility of a high-flux anticancer drug screen using a diverse
RT   panel of cultured human tumor cell lines.";
RL   J. Natl. Cancer Inst. 83:757-766(1991).
//
RX   PubMed=22336246; DOI=10.1016/j.bmc.2012.01.017;
RA   Kong D.-X., Yamori T.;
RT   "JFCR39, a panel of 39 human cancer cell lines, and its application in
RT   the discovery and development of anticancer drugs.";
RL   Bioorg. Med. Chem. 20:1947-1951(2012).
//